PLx Pharma Winddown Corp. Sustainability Profile
PLx Pharma Winddown Corp., headquartered in the United States, operates within the pharmaceutical industry, focusing on the development of innovative drug delivery systems. Founded in 2013, the company has made significant strides in enhancing the safety and efficacy of medications, particularly through its proprietary technology that aims to reduce gastrointestinal side effects. The firm is best known for its unique formulations, which include products designed to improve the bioavailability of non-steroidal anti-inflammatory drugs (NSAIDs). PLx Pharma has established a notable market position, recognised for its commitment to advancing patient care through scientific innovation. As the company transitions into winddown, its legacy in the pharmaceutical sector remains impactful, reflecting a dedication to improving therapeutic outcomes.
DitchCarbon Score
How does PLx Pharma Winddown Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PLx Pharma Winddown Corp.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PLx Pharma Winddown Corp.'s reported carbon emissions
PLx Pharma Winddown Corp., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate commitments, including those aligned with the Science Based Targets initiative (SBTi) or other industry standards. As a result, the company does not appear to have established any significant climate initiatives or pledges at this time. Without emissions data or reduction commitments, it is challenging to assess their environmental impact or sustainability efforts within the broader context of the pharmaceutical industry.
How Carbon Intensive is PLx Pharma Winddown Corp.'s Industry?
How Carbon Intensive is PLx Pharma Winddown Corp.'s Location?
PLx Pharma Winddown Corp.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PLx Pharma Winddown Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
